Company Arsanis Inc Nasdaq
Equities
US0428731097
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 14-06-30 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 16-12-31 |
Chief Tech/Sci/R&D Officer | - | 23-07-31 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 20-11-01 |
Murray Stewart
BRD | Director/Board Member | 63 | 19-03-28 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | 60 | 22-11-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 18-06-30 |
David McGirr
BRD | Director/Board Member | 69 | 17-08-31 |
Paula Ragan
FOU | Founder | 54 | 14-06-30 |
Gary Bridger
BRD | Director/Board Member | 61 | 18-09-30 |
Alison Lawton
BRD | Director/Board Member | 62 | 20-10-04 |
Bill Aliski
BRD | Director/Board Member | 75 | 19-09-17 |
Director/Board Member | 62 | 21-10-13 | |
Murray Stewart
BRD | Director/Board Member | 63 | 19-03-28 |
R. Woods
BRD | Director/Board Member | 56 | 23-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,937,781 | 162,460,401 ( 96.74 %) | 0 | 96.74 % |
Company contact information
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.com![address Arsanis Inc](https://cdn.zonebourse.com/static/address/38702344.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+16.61% | 121B | |
+17.75% | 110B | |
+17.23% | 25.98B | |
-24.11% | 19.27B | |
-18.56% | 15.99B | |
-18.47% | 15.66B | |
-47.75% | 14.5B | |
+57.35% | 14.47B | |
+5.62% | 13.91B |